08:12 AM EDT, 07/31/2026 (MT Newswires) -- AbbVie ( ABBV ) reported Q2 adjusted earnings Friday of $3.65 per diluted share, up from $2.97 a year earlier.

Analysts polled by FactSet expected $3.60.

Net revenue for the quarter ended June 30 was $16.99 billion, up from $15.42 billion a year earlier.

Analysts polled by FactSet expected $16.78 billion.

The company said it expects full-year 2026 adjusted earnings of $13.87 to $14.07 per diluted share, down from its prior guidance of $13.91 to $14.11.

Analysts polled by FactSet expected $14.06.